Kelemen Mark D
Division of Cardiology, University of Maryland School of Medicine, Baltimore, MD 21201-1734, USA.
Med Clin North Am. 2006 May;90(3):391-416. doi: 10.1016/j.mcna.2005.12.002.
Angina pectoris is a clinical manifestation of myocardial ischemia. Complete evaluation consists of a review of risk factors, a careful history, and, typically, a provocative test. Stress testing can be performed with exercise(treadmill, bicycle, or arm ergometry) or pharmacologic agents that increase cardiac work (dobutamine) or dilate the coronary vessels (adenosine or dipyridamole). Patients who have high-risk features found by clinical history or by stress testing should be referred for coronary angiography and possible revascularization. Comprehensive management of patients who have angina (with or without revascularization) includes smoking cessation,diet and weight control, vasculoprotective drugs (aspirin, statins, and possibly ACE inhibitors), and antianginal medications (nitrates, D-blockers, and calcium channel blockers). These strategies have led to an important reduction in morbidity and mortality over the past 2 decades, and the focus on implementing guidelines for patients who are currently undertreated is expected to improve outcomes further.
心绞痛是心肌缺血的一种临床表现。完整的评估包括对危险因素的回顾、详细的病史询问,通常还包括激发试验。负荷试验可通过运动(跑步机、自行车或手臂测力计)或使用增加心脏负荷的药物(多巴酚丁胺)或扩张冠状动脉血管的药物(腺苷或双嘧达莫)来进行。通过临床病史或负荷试验发现具有高危特征的患者应转诊进行冠状动脉造影及可能的血运重建。对心绞痛患者(无论是否进行血运重建)的综合管理包括戒烟、饮食和体重控制、血管保护药物(阿司匹林、他汀类药物,可能还包括血管紧张素转换酶抑制剂)以及抗心绞痛药物(硝酸盐类、β受体阻滞剂和钙通道阻滞剂)。在过去20年中,这些策略已使发病率和死亡率显著降低,而关注对目前治疗不足的患者实施指南有望进一步改善治疗效果。